Australia's largest stock trading and investment forum Australia's #1 stock forum

IMU

6.78%

5.5¢ imugene limited

Serial pumping does not get the share price up.

First 12620 Last

Share
Profile

Follow
rvajna

8,317 Posts.

607

22/03/24

23:35

Post #: 73021909
Share

Originally posted by Taureanbull: ↑

Hawkbar, The company doesn’t need to arrive at its final destination for the share price to move. As I have pointed out several times, the company does want to move onto the NASDAQ. It does have major international investors watching the OASIS trial closely. The company has also employed a corporate strategist.. A lot of money has already been spent preparing for a NASDAQ listing. And we have several trial results for our platforms being released this year.

The stock market is very cable of relating a stock without seeing a big pharma deal. This company has made incredible progress in the last two years. At some stage this progress will be reflected in the share price, Whilst it may seem like it’s sat idle forever this does not predict forward shareprice movement. As with the big effort to push our clinical programs ahead, after we get the results released, the company will use these results as a catalyst to push our ahead our corporate strategy and the share price will respond accordingly.

There is a reason we are seeing this flurry of media activity. Did you also note in the last video of Leslie Chong, mentioned “ a recent presentation to US investors”. Whilst we haven’t seen a video, posted here and do not have any further information, it does hint that she is presenting to them. And it’s unlikely to be Mums and Dads . The US has a quite large and sophisticated BIOTECH focussed investment community. As opposed to Australia that has a very thin sprinkling of mums and dads.

It’s very much my experience that the SP,of a successful Biotexh will rerate rapidly when institutional investors come on board . This hasn’t happened to IMU as yet, in part because dour domestic fund managers don’t touch Biotexh. But US investors have a huge appetite for future disruptive technologies.

And that is exactly what IMU is about to unveil. The results of trials . That’s is why they dumped ALA , because our drugs are so good they don’t need ALA. All of this has been presented in the 4 videos and assorted other social media posts and announcements.

I personally got a lot from Dr Bradley Glovers presentation. And further as I shared with this board, I was lucky enough to have the opportunity to meet him and ask why he joined IMU. He reinforced his reasons again yesterday.

As he is a highly qualified expert on Celular Therapies , I’m very happy to take his word , that we have an amazing portfolio of assets here, And I’m happy to trust that major investors will see this opportunity resulting in a major relating of our share price.A Market Cap of just US$520M is clearly ridiculously low.

Expand

Serial pumping does not get the share price up.

IMU Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

STX

Strike Energy secures $153 million for Perth Basin gas projects

There are more pages in this discussion • 1,677 more messages in this thread...

First 12620 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.5¢		Change -0.004(6.78%)		Mkt cap ! $402.5M

Open	High	Low	Value	Volume
6.0¢	6.1¢	5.5¢	$2.515M	44.29M

Buyers (Bids)

No.	Vol.	Price($)
12	819340	5.5¢

Sellers (Offers)

Price($)	Vol.	No.
5.6¢	515951	4

View Market Depth

No.	Vol.	Price($)
10	736340	0.055
29	2959163	0.054
17	1584508	0.053
19	1719511	0.052
22	3589607	0.051

Price($)	Vol.	No.
0.056	515951	4
0.057	1117035	10
0.058	1866575	10
0.059	2264940	6
0.060	1912026	16

Last trade - 16.10pm 24/06/2024 (20 minute delay)

IMU (ASX) Chart

Serial pumping does not get the share price up.

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Cultural heritage agreement puts Walford Creek exploration back on the map

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Serial pumping does not get the share price up.

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

Cultural heritage agreement puts Walford Creek exploration back on the map

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News